This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Calithera Biosciences, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Sam H. Whiting: Innovator in Cancer Treatment
Introduction
Sam H. Whiting is a notable inventor based in Seattle, WA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of combination therapies to enhance the effectiveness of cancer treatments.
Latest Patents
Sam H. Whiting holds a patent for a groundbreaking invention titled "Combination therapy with glutaminase inhibitors." This invention relates to methods of treating cancer or myeloproliferative diseases using a combination of a glutaminase inhibitor and an anticancer agent selected from cabozantinib, crizotinib, and axitinib. The invention also addresses methods for treating cancer or myeloproliferative diseases that are resistant to one or more anticancer agents. He has 1 patent to his name.
Career Highlights
Sam H. Whiting is currently employed at Calithera Biosciences, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing new treatment options for patients facing challenging medical conditions.
Collaborations
Some of his notable coworkers include Francesco Parlati and Keith Orford, who contribute to the collaborative efforts in research and development at Calithera Biosciences.
Conclusion
Sam H. Whiting's innovative work in cancer treatment exemplifies the impact of combining scientific research with practical applications. His contributions are vital in the ongoing fight against cancer, and his patent reflects a significant advancement in therapeutic strategies.